In 2021, Habrawi et al.37 described the results of percutaneous cryoablation (PCA) used for women with infiltrating ductal carcinomas, ER/PR-positive, and HER2-negative sized 1.5 cm or smaller. This evidence concerns the gene PGR and invasive ductal breast carcinoma.